VanEck Associates
RDHL

VanEck Associates’s Redhill Biopharma RDHL Stock Holding History

VanEck Associates’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8
Closed -$59K – 1306
2021
Q1 		$59K Hold
8
– – ﹤0.01% 1065
2020
Q4 		$65K Hold
8
– – ﹤0.01% 948
2020
Q3 		$84K Hold
8
– – ﹤0.01% 902
2020
Q2 		$54K Sell
8
-3
-27% -$20.7K ﹤0.01% 903
2020
Q1 		$50K Hold
11
– – ﹤0.01% 871
2019
Q4 		$65K Buy
11
+2
+22% +$12.8K ﹤0.01% 870
2019
Q3 		$67K Hold
9
– – ﹤0.01% 780
2019
Q2 		$61K Sell
9
-2
-18% -$15.4K ﹤0.01% 772
2019
Q1 		$92K Hold
11
– – ﹤0.01% 749
2018
Q4 		$60K Buy
11
+3
+38% +$23K ﹤0.01% 753
2018
Q3 		$67K Buy
8
+1
+14% +$8.15K ﹤0.01% 748
2018
Q2 		$61K Buy
7
+3
+75% +$19.1K ﹤0.01% 767
2018
Q1 		$22K Hold
4
– – ﹤0.01% 716
2017
Q4 		$20K Sell
4
-2
-33% -$13.5K ﹤0.01% 713
2017
Q3 		$60K Buy
6
+1
+20% +$8.89K ﹤0.01% 709
2017
Q2 		$45K Sell
5
-25
-83% -$240K ﹤0.01% 725
2017
Q1 		$284K Hold
30
– – ﹤0.01% 655
2016
Q4 		$310K Buy
30
+20
+200% +$240K ﹤0.01% 630
2016
Q3 		$134K Hold
10
– – ﹤0.01% 694
2016
Q2 		$105K Buy
10
+1
+11% +$11.6K ﹤0.01% 683
2016
Q1 		$116K Hold
9
– – ﹤0.01% 662
2015
Q4 		$121K Buy
9
+1
+13% +$12.4K ﹤0.01% 603
2015
Q3 		$109K Buy
8
+1
+14% +$14.8K ﹤0.01% 617
2015
Q2 		$130K Buy
+7
New +$111K ﹤0.01% 629

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM

VanEck Associates's RDHL Position: Q2 2021 in Review

VanEck Associates sold out of Redhill Biopharma (RDHL) in Q2 2021, closing a stake of 8 shares — an estimated $59K sold.

VanEck Associates first reported a position in RDHL in Q2 2015 and held it in 24 quarters. The position peaked at $310K in Q4 2016. 48 funds tracked by Wall St. Rank hold RDHL as of Q2 2021.

  • VanEck Associates reported no remaining Redhill Biopharma position as of Q2 2021 after selling out during the quarter.
  • VanEck Associates sold 8 Redhill Biopharma shares in Q2 2021, an estimated $59K.
  • VanEck Associates first reported a position in Redhill Biopharma in Q2 2015 and held it in 24 quarters.
  • VanEck Associates's Redhill Biopharma position peaked at $310K in Q4 2016.
  • 48 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2021.

Based on VanEck Associates's 13F filing for Q2 2021, filed 10 Aug 2021.